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Abstract The molecular chaperone DnaK is composed of two
functional domains, the ATPase domain and the substrate-bind-
ing domain. In this report, we show that peptide binding to
DnaK can be sensed in real time through a labeled nucleotide
bound in the ATPase domain. Speci¢cally, when N8-(4-NP-
methylanthraniloylaminobutyl)-8-aminoadenosine 5P-triphos-
phate (MABA)^ATPWDnaK complexes are rapidly mixed with
excess peptide, MABA £uorescence rapidly increases and the
rate of increase is proportional to peptide concentration. Anal-
ysis of the formation traces yield on and o¡ rate constants that
are exactly equal to the rate constants obtained from experi-
ments that directly probe peptide binding to DnaK. These re-
sults are the ¢rst to show that peptide binding to ATPWDnaK
triggers a concerted conformational change in the ATPase do-
main.
, 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The Escherichia coli molecular chaperone DnaK functions
co-translationally and post-translationally to promote protein
folding and to prevent and even reverse the formation of toxic
protein aggregates. DnaK shuttles between an ATP-bound
form, which has low a⁄nity for peptide substrates, and an
ADP-bound form, which has relatively high a⁄nity for pro-
tein substrates. For reviews, see [1^4].
DnaK is composed of two functional domains: the N-ter-
minal ATPase domain, which binds and hydrolyzes ATP [5],
is comprised of residues 1^387, whereas the C-terminal sub-
strate-binding domain, which binds and releases polypeptide
targets [6,7], is comprised of residues 388^638. A helical lid,
comprised of residues 507^638, encapsulates the bound pep-
tide in the ADP-bound state. The activities of these two func-
tional domains are coupled, i.e. ligand-induced conformation-
al changes are transmitted in a reciprocal fashion between the
two domains. For example, ATP binding triggers the rapid
release of peptide substrates from the peptide-binding domain
[8,9]. Conversely, peptide binding stimulates DnaK-mediated
ATP hydrolysis [10^12]. It is noteworthy that other than these
observations that peptide stimulates the steady-state hydroly-
sis of ATP by DnaK no evidence exists that peptide binding
directly alters the conformation of the ATPase domain.
Insights into interdomain communication in DnaK have
come about from kinetics studies. The kinetics of the interac-
tion of ATP with DnaK are consistent with the following
mechanism [13]
ð1Þ
In the forward reaction, rapid ATP binding occurs in the ¢rst
step, and a global conformational change occurs in the second
step that ejects the bound peptide and simultaneously reduces
the tryptophan £uorescence of the protein (denoted by the
asterisk). The evidence for this mechanism is that the ATP-
induced decrease in tryptophan £uorescence occurs in a single
phase, and the observed ¢rst-order rate constant, kobs, exhibits
a hyperbolic dependence on ATP. Peptide release may also be
followed directly using a labeled peptide [13,14]. Such rapid
mixing experiments have shown that ATP induces peptide
release at the same rate as the ATP-induced decrease in £uo-
rescence (koff = kobs) [13]. It is intriguing that when a solution
of peptide is mixed with ATPWDnaK* complexes peptide bind-
ing rapidly increases the protein’s tryptophan £uorescence,
consistent with the reversal of the second step of Eq. 1
[13,14]. ATP hydrolysis, we propose, occurs from the inter-
mediate, ATPWDnaKWP.
In this study, we used a £uorescently tagged analog of ATP,
N8-(4-NP-methylanthraniloylaminobutyl)-8-aminoadenosine
5P-triphosphate^ATP (MABA^ATP), to probe reverse reac-
tion 1 in a novel way. MABA^ADP and ^ATP have been
used to probe the kinetics [15] and thermodynamics [16] of
nucleotide binding to DnaK isolated from E. coli as well as
from thermophilic bacteria [17]. This £uorescent derivative of
ATP is the only one that successfully mimics ATP. For exam-
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ple, ATP and MABA^ATP are hydrolyzed by DnaK with
rate constants of 1.5( N 0.1)U1033 s31 and 1.6( N 0.1)U1033
s31 [15], respectively. Here we conducted rapid mixing experi-
ments in which pre-formed MABA^ATPWDnaK complexes
were mixed with unlabeled peptide and show that, remark-
ably, peptide binding to DnaK is sensed in real time via the
MABA^ATP molecule bound in the ATPase domain.
2. Materials and methods
2.1. Protein and reagents
All reagents were of the highest purity and were purchased from
Sigma, unless stated otherwise. DnaK was isolated as previously de-
scribed [18] and maintained in the sample bu¡er (25 mM N-(2-hy-
droxyethyl)piperazine-NP-2-ethanesulfonic acid (HEPES)/50 mM KCl/
5 mM MgCl2/5 mM 2-mercaptoethanol at pH 7.0). Nucleotide was
removed from wild-type DnaK either by exhaustive dialysis [19,20] or
by the method of Gao et al. that employs AMP-p-nitrophenol [21].
Protein was stored in the HEPES sample bu¡ering containing 10%
glycerol at 380‡C prior to use. MABA^ATP (s 95% purity) was
synthesized for us by TriLink BioTechnologies (San Diego, CA,
USA). The p5 (CLLLSAPRR) [22] and Cro (MQERITLKDYAM)
[18] peptides were purchased from Genemed Synthesis (South San
Francisco, CA, USA), puri¢ed to s 95% by high performance liquid
chromatography, and peptide masses was veri¢ed by electrospray
mass spectroscopy. The symbol ‘^’ represents a covalent bond, such
as found between the MABA group and ATP (MABA^ATP), and ‘W’
represents a non-covalent interaction, such as MABA^ATP bound in
the ATPase domain of DnaK (MABA^ATPWDnaK).
2.2. DnaK(1^388)
The pMSK plasmid harboring the wild-type dnaK gene behind an
isopropyl-L-D-thiogalactose-inducible promoter was a gift to us from
Dr. Lila Gierasch (University of Massachusetts, Amherst, MA, USA).
Using the QuikChange Site-Directed Mutagenesis Kit (Stratagene), a
stop codon was introduced into the dnaK gene such that translation
terminates at residue 388. The forward and reverse primers were 5P-
CTG ACT GGT GAC GTA AAA TAA GTA-CTG CTG CTG G-3P
and 5P-CCA GCA GCA GTA CTT ATT TTA CGT CAC CAG-TCA
G-3P, respectively. To ensure that a secondary mutation was not in-
troduced during the polymerase chain reaction protocol, the gene
encoding DnaK(1^388) was sequenced at the Iowa State University
DNA Sequencing and Synthesis Facility. The ATPase domain was
expressed in the DnaK-de¢cient E. coli strain BB1553 [23] and puri-
¢ed and made nucleotide-free using the same methods as for the wild-
type protein.
2.3. Stopped-£ow £uorescence
A SX-18MV stopped-£ow £uorescence spectrometer (Applied Pho-
tophysics, Leatherhead, UK) was used to monitor reverse reaction 1.
The instrument’s features have been described previously in detail
[13,20]. Reverse reaction 1 was followed by mixing MABA^ATPW
DnaK complexes with excess peptide and recording the changes in
MABA £uorescence. The excitation wavelength was 340N 2 nm and
an Oriel 418 nm cut-o¡ ¢lter was used to eliminate wavelengths less
than 418 from impinging on the photomultiplier tube. Each stopped-
£ow trace is the average of four to 10 individual traces. Temperature
control of both the jacketed reactants and the jacketed mixing
chamber was achieved with a circulating external water bath
(vT=N0.2‡C). The concentrations in the text refer to after mixing.
2.4. Curve ¢tting
Stopped-£ow data were ¢tted to single exponential function using a
curve-¢tting program that used a Marquardt algorithm based on the
program Cur¢t given in Bevington [24]. Least squares ¢tting of data
to hyperbolic or linear equations and determinations of standard er-
rors of the ¢tted parameters were conducted using the program Ka-
leidaGraph (Synergy Software, Reading, PA, USA).
3. Results
In the course of using the labeled compound MABA^ATP,
we found that when MABA^ATPWDnaK complexes are mixed
with excess unlabeled peptide a rapid burst of MABA £uo-
rescence occurs. Intrigued by this ¢nding, we analyzed the
reaction in more detail. In the experiments described below,
stopped-£ow experiments were carried out by varying the con-
centration of peptide at a ¢xed concentration of MABA^
ATPWDnaK complexes (3.5 WM).
Representative ‘formation’ traces are shown in Fig. 1A. We
found that the rate and the amplitude of the MABA £uores-
cence signal increase with increasing concentration of the p5
peptide. Traces follow single exponential kinetics. Our inter-
pretation is that peptide binding partially reverses reaction 1,
according to:
Fig. 1. A: Peptide binding enhances the £uorescence of MABA^
ATP bound to DnaK. Traces were obtained upon mixing
MABA^ATPWDnaK (3.5 WM) with increasing concentrations of the
p5 peptide. Each trace follows single exponential kinetics,
FðtÞ ¼ vFð13e3konobs tÞ þ Fo, where konobs, vF, and Fo are the observed
¢rst-order rate constant, amplitude, and initial £uorescence, respec-
tively (solid line). Values for konobs are plotted against [peptide] in
Fig. 3. B: Residuals (theoretical minus experimental). Tempera-
ture= 25‡C.
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MABAATPWDnaK þ PÐk32
k2
MABAATPWDnaKWP ð2Þ
The asterisk in the above equation denotes the low-a⁄nity
state of the protein. MABA^ATPWDnaK* and MABA^
ATPWDnaKWP represent two di¡erent conformations of DnaK.
We propose that a conformational change induced by pep-
tide binding is transmitted from the C-terminal peptide-bind-
ing domain to the N-terminal ATPase domain via changes in
the allosteric interface between the two domains, and this
alters the conformation of the ATPase domain, which causes
the increase in MABA £uorescence.
Several control experiments were conducted. In each exper-
iment, as those above, Vex = 340 nm and Vems 420 nm.
(i) Perhaps the p5 peptide binds to the MABA^ATP molecule
lodged in the ATPase domain of DnaK, and this causes the
increase in MABA £uorescence. Preformed complexes of
MABA^ATPWDnaK(2^388), which is the ATPase domain of
DnaK, were rapidly mixed with excess p5 peptide. No in-
crease in MABA £uorescence is observed (Fig. 2, top trace).
Thus, peptide binding directly to the MABA group lodged in
the ATPase domain of DnaK is ruled out. (ii) If the peptide-
induced increase in MABA £uorescence is truly peptide-spe-
ci¢c, then a non-binder, such as polyglutamic acid, should
have no e¡ect on MABA £uorescence. Indeed, upon mixing
MABA^ATPWDnaK complexes with excess polyglutamic acid,
no change in MABA £uorescence is observed (Fig. 2, middle
trace). This proves that the increase in MABA £uorescence is
peptide-speci¢c. (iii) We have reported that peptide binding to
the ATP-bound state of DnaK results in a rapid increase in
the tryptophan £uorescence of the protein. To rule out the
possibility that the peptide-dependent increase in MABA £uo-
rescence is linked in any way to tryptophan £uorescence, pre-
formed ATPWDnaK* complexes were mixed with excess p5
peptide (Fig. 2, bottom trace). No change in £uorescence is
observed upon mixing. This means that the peptide-induced
increase in MABA £uorescence is unrelated to the presence of
Trp102. (iv) The last control consisted of rapidly mixing
MABA^ATP with excess peptide and monitoring for spectral
changes in MABA £uorescence. This experiment produces no
change in MABA £uorescence (data not shown). The com-
Fig. 2. Controls. The top trace shows the signal obtained upon mix-
ing DnaK(2^388)WMABA^ATP complexes (3.5 WM) with excess p5
peptide (448 WM). The middle trace shows the signal obtained upon
mixing DnaKWMABA^ATP complexes (3.5 WM) with polyglutamic
acid (640 WM). The bottom trace shows the signal obtained upon
mixing DnaKWATP complexes (4 WM) with excess p5 peptide (448
WM). Temperature = 25‡C.
Table 1
Comparison of peptide on and o¡ rate constants for the reaction
ATPWDnaK þ PÐk32
k2
ATPWDnaKWP
Reaction (method)a k2 (s31) k32 (M31 s31)
p5+MABA^ATPWDnaK (MABA £uorescence) 7.0 ( N 1.9) 9.4 ( N 0.2)U105
p5+ATPWDnaK (Trp £uorescence)b 7.0 ( N 3.1) 9.4 ( N 0.4)U105
ap5+ATPWDnaK (acrylodan £uorescence)b 4.5 ( N 1.3) 1.1 ( N 0.1)U106
Cro+MABA^ATPWDnaK (MABA £uorescence) 3.5 ( N 0.2) 2.3 ( N 0.1)U104
Cro+ATPWDnaK (Trp £uorescence)c 2.9 ( N 0.5) 2.4 ( N 0.4)U104
a, acrylodan.
aRate constants were determined by following increases in either MABA £uorescence (of labeled ATP) or tryptophan £uorescence of DnaK, or
acrylodan £uorescence (of the acrylodan-labeled peptide).
bTaken from [14].
cTaken from [13].
Fig. 3. Plots of konobs versus [peptide]. Results are shown for two dif-
ferent peptides, p5 (b) and Cro (F). Solid lines are linear least
square ¢ts to the equation konobs = kon[peptide]+koff . P5: kon = 9.4N
0.2U105 M31 s31 and koff = 7.0 N 1.9 s31 (R=0.9968). Cro: kon =
2.3N 0.1U104 M31 s31 and koff = 3.5N 0.2 s31 (R=0.9986).
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bined experiments show that the C-terminal domain of DnaK
is required for the increase in MABA £uorescence, and the
increase is peptide-speci¢c. The MABA spectral changes are a
consequence of interdomain communication.
The traces shown in Fig. 1 were obtained using the p5
peptide. Identical experiments were also conducted using the
Cro peptide. The observed rate constants for the p5- and Cro-
induced increase in MABA £uorescence are plotted against
peptide concentration in Fig. 3. The linear nature of the plots
is consistent with and expected for reaction 2. From the slope
and y-intercept of the plots we obtain the on and o¡ rate
constants (Table 1). The ‘on’ and ‘o¡’ rate constants deter-
mined from these experiments exactly equal the rate constants
determined from direct binding studies (a direct binding study
is where the peptide is labeled with a £uorophore, and
changes in the labeled peptide’s £uorescence are monitored
upon binding to DnaK [9,18]).
4. Discussion
This is the ¢rst evidence that peptide binding to ATPW
DnaK* is instantaneously sensed within the ATPase domain.
The results lead to the conclusion that interdomain commu-
nication in DnaK occurs via a concerted mechanism. Below
we integrate this new information into the existing mechanism
for reciprocal conformational changes in DnaK.
We know that reaction 1 explains the kinetics of ATP bind-
ing to both the wild-type protein and its various lidless var-
iants. This means that interdomain coupling takes place with-
out the lid, although it is greatly accelerated compared to the
wild-type protein [14]. The role of the lid is to dramatically
slow down the ATP-induced conformational change. Revers-
ing reaction 1, viz. by mixing ATPWDnaK* complexes with
peptide, increases the tryptophan £uorescence of the protein
at a rate that is much greater than the rate of DnaK-mediated
ATP hydrolysis [13]. This reaction is unique because the on
and o¡ rate constants obtained from these experiments exactly
equal the rate constants obtained from direct peptide binding
experiments (Table 1). But why is Trp102 such an excellent
reporter for peptide binding to the low-a⁄nity state of DnaK?
A recent study may shed light on why Trp102 £uorescence
is an accurate reporter for peptide binding. Moro and col-
leagues [25] showed that the ATP-induced decrease in DnaK’s
tryptophan £uorescence is contingent upon the presence of the
KA and 1/2 KB lid helices. Thus, for example, in the lidless
variant DnaK(1^507), which lacks KA helix and all down-
stream residues, ATP induces the high-to-low a⁄nity confor-
mational change in the protein [26] but not the decrease in
tryptophan £uorescence [25]. One idea is that ATP binding
triggers movement of the KA and KB helices into the vicinity
of Trp102, which is located on the outside of one of the lobes
of the ATPase domain, and this changes the environment
around Trp102, which causes quenching. Conversely, peptide
binding to ATPWDnaK* reverses the position of the two lid
helices, which relieves quenching. The spectral changes attrib-
uted to the conformational switch (second step of reaction 1)
are probably due to these reversible changes in the environ-
ment around Trp102 at the domain^domain interface. Since
interdomain communication occurs in the absence of the lid,
producing no changes whatsoever in Trp102 £uorescence, the
existence of these reversible spectral changes in the wild-type
protein, or even in DnaK(2^517), may be thought of as a
byproduct of the primary coupling mechanism. Thus, the pep-
tide-induced increase in Trp102 £uorescence does not neces-
sarily prove that peptide binding produces a conformational
change within the ATPase domain.
The present study is the ¢rst to show that peptide binding
to DnaK triggers an instantaneous conformational change
within the ATPase domain (of the ATPWDnaKWP intermedi-
ate). We infer this from the ability of peptide to trigger an
increase in MABA £uorescence and because the rate constants
derived from this assay exactly equal those obtained by quite
disparate methods (Table 1). On the basis of this work, we
propose that peptide binding to ATPWDnaK* triggers a con-
certed conformational change in the ATPase domain (Fig. 4).
‘Concerted’ means that the conformational change in the
ATPase domain occurs simultaneously with the conforma-
tional change in the substrate-binding domain. It is likely
that this peptide-triggered conformational change in the ATP-
ase domain is key to the entire mechanism of DnaK because it
links DnaK-mediated ATP hydrolysis with substrate binding;
it enables DnaK to hydrolyze ATP more e⁄ciently.
The ATPase and substrate-binding domains of DnaK prob-
ably contact each other over a substantial surface area. Addi-
tionally, the domains are connected via a highly conserved
linker group of residues between the two domains. These con-
tacts and connections enable perfect tight coupling between
the two domains. Zero coupling between the two domains
results in no communication whatsoever between the two do-
mains. There have been several reports where mutations in the
linker [27], or point mutations in other residues at the do-
main^domain interface [28,29], abolish domain^domain com-
munication. In such a mutant, ATP binds and is hydrolyzed
by the ATPase domain, but these two processes have no e¡ect
on substrate binding and release by the substrate-binding do-
main. It will be interesting to ¢nd point mutations in DnaK
that reduce but do not eliminate the coupling between the two
domains.
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